These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 6134926)

  • 1. Tetrahydrobiopterin levels in cerebrospinal fluid of affectively ill patients.
    Kellner CH; Rakita RM; Rubinow DA; Gold PW; Ballenger JC; Post RM
    Lancet; 1983 Jul; 2(8340):55-6. PubMed ID: 6134926
    [No Abstract]   [Full Text] [Related]  

  • 2. Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type.
    Morar C; Whitburn SB; Blair JA; Leeming RJ; Wilcock GK
    J Neurol Neurosurg Psychiatry; 1983 Jun; 46(6):582. PubMed ID: 6875596
    [No Abstract]   [Full Text] [Related]  

  • 3. CSF tetrahydrobiopterin levels in patients with affective disorders.
    Levine RA; Lovenberg W
    Lancet; 1984 Feb; 1(8371):283. PubMed ID: 6143025
    [No Abstract]   [Full Text] [Related]  

  • 4. Tetrahydrobiopterin in dihydropteridine reductase deficiency.
    Howells D; Smith I; Leonard J; Hyland K
    N Engl J Med; 1986 Feb; 314(8):520-1. PubMed ID: 3945285
    [No Abstract]   [Full Text] [Related]  

  • 5. Low CSF hydroxylase cofactor (tetrahydrobiopterin) levels in inherited dystonia.
    Williams A; Eldridge R; Levine R; Lovenberg W; Paulson G
    Lancet; 1979 Aug; 2(8139):410-1. PubMed ID: 89462
    [No Abstract]   [Full Text] [Related]  

  • 6. Hydroxylase cofactor activity in cerebrospinal fluid of normal subjects and patients with Parkinson's disease.
    Lovenberg W; Levine RA; Robinson DS; Ebert M; Williams AC; Calne DB
    Science; 1979 May; 204(4393):624-6. PubMed ID: 432666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid hydroxylase cofactor in schizophrenia.
    Garbutt JC; van Kammen DP; Levine RA; Sternberg DE; Murphy DL; Ballenger J; Bunney WE; Lovenberg WM
    Psychiatry Res; 1982 Apr; 6(2):145-51. PubMed ID: 6953456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging and CSF hydroxylase cofactor.
    Williams A; Ballenger J; Levine R; Lovenberg W; Calne D
    Neurology; 1980 Nov; 30(11):1244-6. PubMed ID: 7191523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary evaluation of hydroxylase cofactor in human spinal fluid: potential biochemical and clinical relevance for psychiatric disorders.
    van Kammen DP; Levine R; Sternberg D
    Psychopharmacol Bull; 1978 Oct; 14(4):51-2. PubMed ID: 704761
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxylase cofactor in human CSF--an index of central aminergic activity.
    Robinson DS; Levine R; Williams A; Statham N
    Psychopharmacol Bull; 1978 Oct; 14(4):49-51. PubMed ID: 704760
    [No Abstract]   [Full Text] [Related]  

  • 11. Successful treatment of depression with tetrahydrobiopterin.
    Curtius HC; Niederwieser A; Levine RA; Lovenberg W; Woggon B; Angst J
    Lancet; 1983 Mar; 1(8325):657-8. PubMed ID: 6131342
    [No Abstract]   [Full Text] [Related]  

  • 12. Tyrosine hydroxylase cofactor (tetrahydrobiopterin) in parkinsonism.
    LeWitt PA; Miller LP; Newman RP; Burns RS; Insel T; Levine RA; Lovenberg W; Calne DB
    Adv Neurol; 1984; 40():459-62. PubMed ID: 6421110
    [No Abstract]   [Full Text] [Related]  

  • 13. Direct analysis of tetrahydrobiopterin in cerebrospinal fluid by high-performance liquid chromatography with redox electrochemistry: prevention of autoxidation during storage and analysis.
    Howells DW; Hyland K
    Clin Chim Acta; 1987 Jul; 167(1):23-30. PubMed ID: 3665086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The tetrahydrobiopterin pathway: a novel target for the treatment of depression.
    McHugh PC
    Pharmacogenomics; 2011 Dec; 12(12):1625-7. PubMed ID: 22118047
    [No Abstract]   [Full Text] [Related]  

  • 15. Unsuccessful treatment of depression with tetrahydrobiopterin.
    Woggon B; Angst J; Curtius HC; Niederwieser A
    Lancet; 1984 Dec; 2(8417-8418):1463. PubMed ID: 6151068
    [No Abstract]   [Full Text] [Related]  

  • 16. Tetrahydrobiopterin in dystonia: identification of abnormal metabolism and therapeutic trials.
    LeWitt PA; Miller LP; Levine RA; Lovenberg W; Newman RP; Papavasiliou A; Rayes A; Eldridge R; Burns RS
    Neurology; 1986 Jun; 36(6):760-4. PubMed ID: 3703282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic efficacy of tetrahydrobiopterin in Parkinson's disease.
    Curtius HC; Niederwieser A; Levine R; Müldner H
    Adv Neurol; 1984; 40():463-6. PubMed ID: 6695623
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of tetrahydropterins in the treatment of hyperphenylalaninemia due to defective synthesis of tetrahydrobiopterin: evidence that peripherally administered tetrahydropterins enter the brain.
    Kaufman S; Kapatos G; McInnes RR; Schulman JD; Rizzo WB
    Pediatrics; 1982 Sep; 70(3):376-80. PubMed ID: 7110811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid nitrite plus nitrate correlates with tetrahydrobiopterin concentration.
    Heales SJ; Canevari L; Brand MP; Clark JB; Land JM; Hyland K
    J Inherit Metab Dis; 1999 May; 22(3):221-3. PubMed ID: 10384372
    [No Abstract]   [Full Text] [Related]  

  • 20. Changes in plasma tetrahydrobiopterin levels of depressives in depressive and remission phases: reconfirmed by measurement with an internal standard.
    Hashimoto R; Mizutani M; Ohta T; Nakazawa K; Nagatsu T
    Neuropsychobiology; 1994; 29(2):57-60. PubMed ID: 8170526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.